NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	The subjects undergoing cerebral angiography
Date of first enrollment	22/04/2014
Target sample size	100
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : GE-145 INN of investigational material : Ioforminol (INN) Therapeutic category code : 721 X-ray contrast agents Dosage and Administration for Investigational material : Injection control material(s) Generic name etc : Iodixanol INN of investigational material : Iodixanol (INN) Therapeutic category code : 721 X-ray contrast agents Dosage and Administration for Investigational material : Injection

Outcome(s)

Primary Outcome	Image quality Evaluation based on a criteria
Secondary Outcome	Safety Adverse events after the administration of the study drug

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	The subjects who will undergo cerebral angiography with or without endovascular treatment.
Exclude criteria